Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$38.65 - $43.48 $228,885 - $257,488
5,922 Added 18.11%
38,626 $1.55 Million
Q1 2024

May 03, 2024

BUY
$42.85 - $63.45 $18,168 - $26,902
424 Added 1.31%
32,704 $1.44 Million
Q4 2023

Feb 08, 2024

SELL
$44.49 - $62.93 $3,737 - $5,286
-84 Reduced 0.26%
32,280 $2 Million
Q3 2023

Nov 09, 2023

SELL
$45.51 - $65.0 $35,907 - $51,285
-789 Reduced 2.38%
32,364 $1.49 Million
Q2 2023

Aug 07, 2023

SELL
$35.77 - $58.38 $23,429 - $38,238
-655 Reduced 1.94%
33,153 $1.91 Million
Q1 2023

May 01, 2023

BUY
$27.99 - $37.92 $236,907 - $320,954
8,464 Added 33.4%
33,808 $1.27 Million
Q4 2022

Feb 07, 2023

SELL
$27.93 - $31.27 $60,189 - $67,386
-2,155 Reduced 7.84%
25,344 $710,000
Q3 2022

Oct 25, 2022

BUY
$27.56 - $37.75 $8,901 - $12,193
323 Added 1.19%
27,499 $773,000
Q2 2022

Aug 08, 2022

BUY
$29.79 - $42.29 $31,458 - $44,658
1,056 Added 4.04%
27,176 $945,000
Q1 2022

May 06, 2022

SELL
$22.96 - $36.45 $10,148 - $16,110
-442 Reduced 1.66%
26,120 $938,000
Q4 2021

Feb 08, 2022

SELL
$18.14 - $23.29 $14,457 - $18,562
-797 Reduced 2.91%
26,562 $619,000
Q3 2021

Oct 28, 2021

BUY
$17.83 - $21.49 $445 - $537
25 Added 0.09%
27,359 $520,000
Q2 2021

Jul 27, 2021

BUY
$17.11 - $20.92 $119 - $146
7 Added 0.03%
27,334 $551,000
Q1 2021

May 03, 2021

SELL
$17.21 - $20.65 $35,160 - $42,187
-2,043 Reduced 6.96%
27,327 $501,000
Q4 2020

Feb 04, 2021

SELL
$17.76 - $21.24 $84,963 - $101,612
-4,784 Reduced 14.01%
29,370 $591,000
Q3 2020

Nov 06, 2020

BUY
$17.99 - $22.22 $135,086 - $166,849
7,509 Added 28.18%
34,154 $640,000
Q2 2020

Aug 04, 2020

SELL
$14.25 - $22.46 $35,340 - $55,700
-2,480 Reduced 8.52%
26,645 $598,000
Q1 2020

Apr 27, 2020

BUY
$12.66 - $20.08 $72,010 - $114,215
5,688 Added 24.27%
29,125 $432,000
Q4 2019

Feb 03, 2020

SELL
$17.07 - $20.64 $477 - $577
-28 Reduced 0.12%
23,437 $452,000
Q3 2019

Oct 31, 2019

SELL
$19.12 - $22.62 $9,387 - $11,106
-491 Reduced 2.05%
23,465 $465,000
Q2 2019

Aug 09, 2019

BUY
$18.92 - $22.96 $9,100 - $11,043
481 Added 2.05%
23,956 $506,000
Q1 2019

May 02, 2019

BUY
$19.46 - $25.28 $16,560 - $21,513
851 Added 3.76%
23,475 $480,000
Q4 2018

Feb 11, 2019

BUY
$17.72 - $22.51 $14,105 - $17,917
796 Added 3.65%
22,624 $450,000
Q3 2018

Oct 22, 2018

SELL
$15.39 - $19.38 $20,576 - $25,911
-1,337 Reduced 5.77%
21,828 $420,000
Q2 2018

Jul 23, 2018

SELL
$14.63 - $19.6 $3,979 - $5,331
-272 Reduced 1.16%
23,165 $353,000
Q1 2018

Apr 20, 2018

SELL
$17.23 - $20.35 $8,511 - $10,052
-494 Reduced 2.06%
23,437 $439,000
Q4 2017

Jan 23, 2018

SELL
$17.76 - $19.75 $36,177 - $40,230
-2,037 Reduced 7.84%
23,931 $460,000
Q3 2017

Nov 13, 2017

BUY
$14.73 - $17.99 $382,508 - $467,164
25,968
25,968 $464,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.64B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Texas Permanent School Fund Portfolio

Follow Texas Permanent School Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.